JMP Securities maintains PTGX stock with $58 target
JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...
Affirm stock price target raised to $85 at JMP Securities
JMP Securities updated its outlook on Affirm Holdings Inc. (NASDAQ: NASDAQ:AFRM), increasing the price target to $85 from the ...
Cloudflare price target raised to $180 from $135 at JMP Securities
JMP Securities raised the firm’s price target on Cloudflare (NET) to $180 from $135 and keeps an Outperform rating on the shares. Cloudflare ...
JMP Securities Sticks to Their Buy Rating for Cytokinetics (CYTK)
JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.